Galaxy receives CE mark for brain aneurysm system
· shani alexander
AI Briefing
- • Galaxy Therapeutics Inc. received CE mark approval for its SEAL embolization system for brain aneurysm treatment.
- • The device is designed for wide-neck intracranial aneurysms and simplifies treatment for complex anatomies.
- • SEAL system offers physicians an alternative option for wide neck bifurcation aneurysms.
Context
Galaxy Therapeutics Inc. has received CE mark approval for its SEAL embolization system. The system is designed to treat ruptured and unruptured wide-neck intracranial aneurysms.
The approval of the SEAL embolization system matters because it provides physicians with an alternative option for treating wide neck bifurcation aneurysms and can simplify aneurysm treatment for a broad range of complex anatomies.
Advertisement